Investor Relations

SEC Filings

Document Details

Filing Date
Dec 18, 2024
Document Date
Jan 28, 2025
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.